With 289 Rare Diseases related patents published between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in Colombia.
The second largest number of Rare Diseases related patents were published by F. Hoffmann-La Roche Ltd with 233 patents. The third largest number of Rare Diseases related patents were published by Novartis AG with 188 patents. The fourth largest number of Rare Diseases related patents were published by AstraZeneca Plc with 173 patents, of which 84.4% was contributed by AstraZeneca AB. The fifth largest number of Rare Diseases related patents were published by Sanofi with 172 patents.
The top five patent holders, i.e., Pfizer Inc, F. Hoffmann-La Roche Ltd, Novartis AG, AstraZeneca Plc, and Sanofi, together held 1,055 Rare Diseases patents during the period.
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward